Extract of medicinal plant Artemisia annua interferes with replication of SARS-CoV-2 in vitro

Researchers in the United States have shown that extracts of an aromatic herb called Artemisia annua inhibit the replication of severe acute respiratory coronavirus (SARS-CoV-2) – the agent responsible for the current coronavirus disease 2019 (COVID-19) pandemic.

Artemisia annua L. extracts prevent in vitro replication of SARS-CoV-2

Robust Antiviral Activity of Santonica Flower Extract (Artemisia cina) against Avian and Human Influenza A Viruses: In Vitro and Chemoinformatic Studies

Antiviral, virucidal and antioxidant properties of Artemisia annua against SARS-CoV-2 - ScienceDirect

Frontiers Medicinal Plants and Isolated Molecules Demonstrating Immunomodulation Activity as Potential Alternative Therapies for Viral Diseases Including COVID-19

Artemisia annua L. and Its Derivatives: Their Antiviral Effects on COVID-19 and Possible Mechanisms

Artemisia plant extract prevents SARS-CoV-2 replication in vitro

Antiviral, virucidal and antioxidant properties of Artemisia annua against SARS-CoV-2 - ScienceDirect

Frontiers Anti–SARS-CoV-2 Natural Products as Potentially Therapeutic Agents

Umbelliferone and eriodictyol suppress the cellular entry of SARS-CoV-2, Cell & Bioscience

Instant determination of the artemisinin from various Artemisia annua L. extracts by LC‐ESI‐MS/MS and their in‐silico modelling and in vitro antiviral activity studies against SARS‐CoV‐2 - Dogan - 2022 - Phytochemical Analysis

SARS-CoV-2 omicron variants are susceptible in vitro to Artemisia annua hot water extracts - ScienceDirect

Traditional Medicinal Plants as the Potential Adjuvant, Prophylactic and Treatment Therapy for COVID-19 Disease: A Review